Epidemiology, outcomes of treatment, and survival of cervical cancer in Kazakhstan: a nationwide population-based study - Takeaways - MDSpire

Epidemiology, outcomes of treatment, and survival of cervical cancer in Kazakhstan: a nationwide population-based study

  • By

  • Aidana Rakhmankulova

  • Yesbolat Sakko

  • Abduzhappar Gaipov

  • Kuralay Atageldiyeva

  • Talshyn Ukybassova

  • Assem Suleimenova

  • Yerbolat Iztleuov

  • Gulzhanat Aimagambetova

  • June 5, 2026

  • 0 min

Share

  • 1

    Cervical cancer prevalence in Kazakhstan increased over a decade, with age-standardized incidence and mortality rates peaking in 2022.

  • 2

    The disability-adjusted life year (DALY) rate for cervical cancer sharply rose to 255.24 per 100,000 women in 2022.

  • 3

    The 5-year survival rate for cervical cancer in Kazakhstan is 65.3%, with poorer outcomes observed in advanced stages.

  • 4

    Kazakhstan's first HPV vaccination campaign began in 2013 but was halted in 2015 due to misinformation, with a new campaign starting in 2024.

  • 5

    Cervical cancer screening coverage in Kazakhstan remains low and inconsistent, with rates ranging from 46% in 2016 to 92% in 2021-2022.

Original Source(s)

Related Content